Using modern biology this project has uncovered a platform to make complex natural products to be exploited for unmet medical needs.
Frank Hoover
Senior Innovation Manager, Group lead
fho [at] visinnovasjon.no
Follow Frank in social media
Frank has a background as a researcher and group leader in Academia and the Biotechnology Industry. For more than 20 years he has been driven by hypotheses related to molecular mechanisms that control the central nervous system communication, development and disease through molecular and biological techniques. Now he uses the knowledge he has accumulated against research-based startup companies.
At VIS he looks for the good innovative ideas of the owner institutions.
Next to giving advises, he looks for finance opportunities, provides intangible protection and develops commercialization strategies
He enjoys working closely with the researchers behind the idea when developing projects, and helping researchers get Eureka moments.
Also in private, Frank focuses on sustainability and helping things to grow, through horticulture and beekeeping.
Education: Dr. Philos. in Biological Chemistry, University of Michigan.
Prosjektleder for:
Therapies against cancer are challenging due to the heterogeneity of cancer cells. This project represents a strong collaboration between two disciplines coming together to develop novel molecules for cancer treatment.
Understanding and developing treatments for Central Nervous Disease (CNS) has been hampered by the complexity and the uniqueness of the CNS. This project aims to identify relevant pathways and molecules that can be targeted so that better treatments can evolve.